Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
ConditionPeripheral Arterial Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorMayo Clinic
About this trial
The purpose of this study is to develop a new noninvasive tool for early diagnosis of Peripheral Arterial Disease (PAD) and use the proposed method for monitoring the disease progression and the response to interventional treatment in PAD patients.
Eligibility criteria
Qualifiers
Male and Female, ages 18 years old and up
Symptom of claudication and suspected for PAD
Scheduled for vascular testing.
Male and female, ages 18-75 years old and up
Disqualifiers
Patients with gangrene
Patients having surgery or stent
Patients with ulcer on their leg
Any health condition that does not allow proper use of ultrasound scanning
Trial design
Treatments tested in this trial
- Ultrasound Imaging
Treatment groups
400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Mayo Clinic
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov